Atlas Trials

Bioray Laboratories

24 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Bioray Laboratories

RecordFirmDate
Universal CAR-T Cell Therapy for MM (NCT07248176)Bioray Laboratories2025-04-10
Universal CAR-T Cell Therapy for NHL (NCT07248163)Bioray Laboratories2025-03-11
Long-term Follow-up Study of BRL-101 for TDT (NCT06298630)Bioray Laboratories2024-12-08
The Safety and Efficacy of Universal CAR-T Cells Targeting BCMA in the Treatment of Refractory NMOSD (NCT06633042)Bioray Laboratories2024-11-25
Universal CAR-T Cell Therapy for Refractory Lupus Nephritis (NCT06681337)Bioray Laboratories2024-11-25
Clinical Study of BRL-101 in Severe SCD (NCT06300723)Bioray Laboratories2024-07-29
Clinical Study on the Safety and Efficacy of BRL-101 in the Treatment of Sickle Cell Disease (NCT06287086)Bioray Laboratories2024-06-14
Clinical Study of BRL-101 in the Treatment of Sickle Cell Disease (NCT06287099)Bioray Laboratories2024-04-20
Efficacy and Safety Evaluation of PD1-BCMA-CART (NCT05308875)Bioray Laboratories2024-03-01
Safety and Efficacy Evaluation of γ-globin Reactivated Autologous Hematopoietic Stem Cells (NCT05442346)Bioray Laboratories2023-12-25
Safety and Efficacy Evaluation of Next-generation CD19-UCART (NCT05381181)Bioray Laboratories2023-12-20
Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus Erythematosus (NCT05988216)Bioray Laboratories2023-08-14
Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases (NCT05859997)Bioray Laboratories2023-05-17
The Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin Lymphoma (NCT05741359)Bioray Laboratories2023-04-25
Long-term Follow-up Study of BHC001 for TDT (NCT06314529)Bioray Laboratories2022-12-14
Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia (NCT05577312)Bioray Laboratories2022-11-02
Safety and Efficacy Evaluation of BCMA-CART for Treating Multiple Myeloma (NCT03492268)Bioray Laboratories2021-11-01
β-globin Restored Autologous HSC in β-thalassemia Major Patients (NCT04205435)Bioray Laboratories2021-11-01
Safety and Efficacy Evaluation of γ-globin Reactivated Autologous Hematopoietic Stem Cells (NCT04211480)Bioray Laboratories2020-10-01
LIGHT-PSMA-CART in Treating Patients With Castrate-Resistant Prostate Cancer (NCT04053062)Bioray Laboratories2020-07-16
PD1-CD19-CART in Patients With r/r B-cell Lymphoma (NCT04213469)Bioray Laboratories2020-03-13
Efficacy and Safety Evaluation of BCMA-UCART (NCT03752541)Bioray Laboratories2019-11-01
Safety and Efficacy Evaluation of CD19-UCART (NCT03229876)Bioray Laboratories2019-06-01
CD19-CART Treatment for ALL (NCT03232619)Bioray Laboratories2018-08-01

Track Bioray Laboratories automatically

Every clearance here is in the API, with alerts when new ones post.